Insiders Updates
Collegium Pharmaceutical Inc (COLL) Becoming More Attractive for Investors
Collegium Pharmaceutical Inc’s filing revealed that its EVP and Chief Medical Officer Smith Thomas B unloaded Company’s shares for reported
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.